Clinicians should maintain a high index of suspicion and consult their local and state health departments and CDC when ill travelers from Ebola-affected countries are identified; it is important to recognize that the likelihood of EVD even among symptomatic travelers returning from these countries is very low. In the hospital setting, where policies and procedures should be in place to safeguard health care workers, consideration of Ebola should not delay diagnostic assessments, laboratory testing, and appropriate care for other, more likely medical conditions.
Due to a heightened concern in the United States about Ebola, the Centers for Disease Control and Prevention (CDC) has issued guidance for clinical laboratories on testing needed for the assessment and care of patients for which Ebola Virus Disease (EVD) is a concern, while minimizing risk to laboratory personnel. This document updates and replaces the previously issued guidance, "How U.S. Laboratories Can Safely Manage Specimens from Persons Under Investigation for Ebola Virus Disease."
Clinicians should maintain a high index of suspicion and consult their local and state health departments and CDC when ill travelers from Ebola-affected countries are identified; it is important to recognize that the likelihood of EVD even among symptomatic travelers returning from these countries is very low. In the hospital setting, where policies and procedures should be in place to safeguard healthcare workers, consideration of Ebola should not delay diagnostic assessments, laboratory testing, and appropriate care for other, more likely medical conditions. This guidance is based on input received from numerous hospital and laboratory directors, infectious disease physicians, CDC Ebola response teams, and state health officials.
To read the document, "Guidance for U.S. Laboratories for Managing and Testing Routine Clinical Specimens When There is a Concern About Ebola Virus Disease," CLICK HERE.
Beyond the Surface: Rethinking Environmental Hygiene Validation at Exchange25
June 30th 2025Environmental hygiene is about more than just shiny surfaces. At Exchange25, infection prevention experts urged the field to look deeper, rethink blame, and validate cleaning efforts across the entire care environment, not just EVS tasks.
A Controversial Reboot: New Vaccine Panel Faces Scrutiny, Support, and Sharp Divides
June 26th 2025As the newly appointed Advisory Committee on Immunization Practices (ACIP) met for the first time under sweeping changes by HHS Secretary Robert F. Kennedy Jr, the national spotlight turned to the panel’s legitimacy, vaccine guidance, and whether science or ideology would steer public health policy in a polarized era.
Getting Down and Dirty With PPE: Presentations at HSPA by Jill Holdsworth and Katie Belski
June 26th 2025In the heart of the hospital, decontamination technicians tackle one of health care’s dirtiest—and most vital—jobs. At HSPA 2025, 6 packed workshops led by experts Jill Holdsworth and Katie Belski spotlighted the crucial, often-overlooked art of PPE removal. The message was clear: proper doffing saves lives, starting with your own.